Before mass-producing and launching a product into the market, R&D is a crucial stage that often involves numerous tasks and generates an enormous amount of data. If all data from a big project are recorded in hard copies, a…
eBook Despite many companies considering digital transformation a top priority, research shows that 70% of digital transformation initiatives fail. In this eBook, we explore why and how the right approach can see your organization succeed. Download our eBook to discover…
When collaborating with external partners, a biopharma company must anticipate communication challenges related to a large volume and variety of documents, regulation-compliant storage of data, and real-time visibility and control. This paper shows how an online collaboration system can…
TetraScience, the world’s first and only open R&D Data Cloud for scientific discovery, and IDBS, a leading R&D technology and solutions provider, announce a strategic partnership to integrate IDBS E-WorkBook and Tetra Data Platform into a common ecosystem to provide end-to-end R&D data automation.
LabVoice, which provides a workflow engine for scientific voice assistants, and IDBS, a leading R&D technology and solutions provider, are excited to announce an integration to accelerate research, innovation, and design.
IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), today announced the launch of Polar BioAnalysis, bringing consistency, quality, and reproducibility to preclinical drug qualification.
Pharmaceutical companies generate a wealth of data and, with most investing in technologies to enable high throughput experimentation and automation, the speed at which new data is generated is rapidly increasing. However, most organizations are unable to gain actionable insights…
eBook What it means to be F.A.I.R. Research data is often not used past its intended purpose. In fact, in many cases, scientific data is not shared or even re-usable. This could be due to data protection or because the data is…
Webinar | Presented on 16 Aug 2019Fewer than 50 percent of preclinical research studies, conducted at a cost of $28 billion per year, are reproducible. Rigor in bioanalytical method validation is emerging in the form of a global standard: preclinical studies are increasingly…
VideoIDBS has been helping the world’s leading pharmaceutical and biotech companies for decades. Watch our video to find out how!Transcription IDBS delivers solutions in the preclinical development area, providing an end-to-end solution for pharmacology, drug metabolism…
